Work

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

Year: 2020

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2020.10.019

Authors: Maria M. Rubinstein, Rachel N. Grisham, Karen Cadoo, Chrisann Kyi, William P. Tew, Claire F. Friedman, Roisin E. O'Cearbhaill, Dmitriy Zamarin, Qin Zhou, Alexia Iasonos, Ines Nikolovski, Hongmei Xu, Krysten N. Soldan, Imogen Caird, Madhuri Martin, Joyce Guillen, Khalil T. Eid, Carol Aghajanian, Vicky Makker

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Karyopharm Therapeutics (United States)

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G589551644, Cancer Center Support Grant

OpenAlex ID: W3095281314

FWCI: 1.624

Cites: 33

Cited by: 15

Related to: 10